Cargando…
Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation
Objective: Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary given the increased prevalence of multidrug-resistant infections in intensive care units coupled with the limited number of available treatment options. Unfortunately, recommended dose regimens of NBLA based on PK...
Autores principales: | Bakdach, Dana, Elajez, Reem, Bakdach, Abdul Rahman, Awaisu, Ahmed, De Pascale, Gennaro, Ait Hssain, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738279/ https://www.ncbi.nlm.nih.gov/pubmed/36498473 http://dx.doi.org/10.3390/jcm11236898 |
Ejemplares similares
-
β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance
por: Jacobs, Alexandra, et al.
Publicado: (2018) -
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
por: Luci, Giacomo, et al.
Publicado: (2021) -
Hospital pharmacists’ self-evaluation of their competence and confidence in conducting pharmacy practice research
por: Awaisu, Ahmed, et al.
Publicado: (2015) -
Pharmacodynamic optimization of β-lactams in the patient care setting
por: Nicolau, David P
Publicado: (2008) -
BADAN-conjugated β-lactamases as biosensors for β-lactam antibiotic detection
por: Au, Ho-Wah, et al.
Publicado: (2020)